The advisory committee voted 8-8 on approving the drug, to be called Zynquista, which would be the first oral medication for people with Type 1 diabetes.
Published: January 17, 2019 at 01:00AM
from NYT Health https://nyti.ms/2FGsGur
The advisory committee voted 8-8 on approving the drug, to be called Zynquista, which would be the first oral medication for people with Type 1 diabetes.
Published: January 17, 2019 at 01:00AM
from NYT Health https://nyti.ms/2FGsGur